The Ultimate Dividend King Drug Stock to Buy With $1,000 Right Now

The healthcare sector is both large and important, and one of its most exciting areas is the pharmaceutical niche. That's always true from a development standpoint. Right now, it's also true from the regulatory side of things.But that excitement isn't necessarily for a good reason. Changes underway in Washington have put drugmakers, particularly those that make vaccines, in Wall Street's doghouse. A growing issue with trust from consumers concerning drug makers has been negative, as well.As a result, some of the largest drug makers have seen their stock prices fall dramatically in recent years (see chart below).Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool